DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lawitz E, Kowdley K, Curry M. et al.
High Efficacy of Sofosbuvir/Velpatasvir Plus Gs-9857 for 12 Weeks in Treatment-Experienced Genotype 1–6 Hcv-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals.
Journal of hepatology 2016;
64: S139-S140
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.